Wed, Nov 16|
SKIN DEEP: The connection between skin health & the microbiome
APC Microbiome Ireland brings together some of Ireland’s top skincare professionals for an exciting evening event exploring the ground-breaking world of the skin microbiome.
Time & Location
Nov 16, 2022, 7:00 PM – 9:00 PM
Hayfield Manor, Perrott Ave, College Rd, Centre, Cork, T12 HT97, Ireland
About the Event
Discover about the science behind skincare, how your microbiome influences your skin health and what to look out for in skincare products to target your microbes.
RTE broadcaster and science communicator Kathriona Devereux will lead the discussion featuring voices from skin and microbiome research, dermatology, the beauty industry, and product regulation and development.
- Corinna Tolan – Monica Tolan Beauty & Skincare Clinic
- Dr Julie O’ Sullivan – APC Microbiome Ireland, UCC
- Dr Nonhlanhla Lunjani – APC Microbiome Ireland, UCC
- Claire Tansey – Atlantia Clinical Trials
- Michelle McDonald & Dr Brian O’ Rourke - Sásta Skin Health
Date: Wednesday 16th November
Time: 7PM – 9PM
Venue: Hayfield Manor Hotel, Perrott Avenue, College Road, Cork
About APC Microbiome Ireland:
APC Microbiome Ireland is a world-leading SFI Research Centre based in University College Cork and Teagasc. It was formed in 2003 with funding from Science Foundation Ireland and in conjunction with key industry partners. APC represents a seamless collaboration between University College Cork and Teagasc (the Irish Agriculture and Food Development Authority). It is widely recognised that the gut microbiota plays an important role in human health and has become one of the most dynamic, complex and exciting areas of research in both food and pharmaceutical arenas. Over the last decade APC has established itself as one of the leading global centres in gut microbiota research.
APC has made several landmark discoveries and has published over 3,000 research articles in peer-reviewed journals, generating many journal covers and associated editorials. Recent research areas being led by APC include the development of new diagnostics or biomarkers of health or risk of disease (e.g. colon cancer) based on analysis of the microbiota; exploring the mechanisms by which the microbiota may be favourably mobilised or manipulated (e.g. by bacteriophage) to promote health and ‘mining’ the microbiota for new drugs (e.g. smart antibiotics) and functional food ingredients. For more information, please visit https://apc.ucc.ie or follow APC Microbiome Ireland on Twitter, LinkedIn, Instagram or Facebook